Investment Summary |
|
|---|---|
| Date | 2017-09-28 |
| Target | Stockpile |
| Sector | Internet Software and Services |
| Investor(s) | Eight Roads |
| Deal Type | Venture |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1969 |
| PE ASSETS | 11.0B USD |
| Size | Mega |
| Type | Sector Focused |
Eight Roads is a private investment firm focused on a variety of investment opportunities across the US, Europe, and Asia. The Firm is divided into several investment strategies including venture, principal investing, and real estate. Within the principal investments group, Eight Roads backs established growth businesses with long-term capital. Eight Roads does not have any sector preferences, but has experience in fintech, business services, and healthcare. Eight Roads is based in London.
| DEAL STATS | # |
|---|---|
| Overall | 166 of 293 |
| Sector: Internet Software and Services M&A | 38 of 60 |
| Type: Venture M&A Deals | 145 of 266 |
| State: California M&A | 23 of 42 |
| Country: United States M&A | 76 of 119 |
| Year: 2017 M&A | 31 of 38 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-09-19 |
Threat Stack
Boston, Massachusetts, United States Threat Stack is involved in providing cloud security and compliance for infrastructure and applications, helping companies securely leverage the business benefits of the cloud with proactive risk identification and real-time threat detection across cloud workloads. The Threat Stack Cloud Security Platform delivers full-stack security observability across the cloud management console, host, container, orchestration, managed containers, and serverless layers. It provides the flexibility to consume telemetry within existing security workflows or manages it with clients through the Threat Stack Cloud SecOps Program to respond to security incidents and improve the organization’s cloud security posture over time. Threat Stack was founded in 2012 and is based in Boston, Massachusetts. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-10-03 |
Dimension Therapeutics
Cambridge, Massachusetts, United States Dimension Therapeutics is a developer of new therapeutic products for people living with devastating rare and metabolic diseases associated with the liver, based on the most advanced mammalian adeno-associated virus (AAV) gene delivery technology. Dimension Therapeutics was founded in 2013 and is based in Cambridge, Massachusetts. |
Sell | $151M |
